CF PharmTech, Inc. (02652) Announces Share Repurchase and Updated Issued Shares

Bulletin Express02-24

CF PharmTech, Inc. (02652) disclosed that on 24 February 2026, the company repurchased 27,000 shares at prices ranging from HKD 36.60 to HKD 37.18, with a total payment of HKD 997,440. These repurchased shares will be held as treasury shares, bringing the total number of treasury shares to 0.39 million.

Following this transaction, the number of shares excluding treasury shares stands at 301.83 million, while the overall issued share count remains at 302.22 million. The repurchase forms part of an authorized mandate to buy back up to 30.22 million shares, with 0.39 million shares repurchased to date. A moratorium imposed on new share issuance or treasury share transactions is in place until 26 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment